AstraZeneca CEO strikes bullish tone on pipeline as stock rallies | live
By Pushkala Aripaka and Patrick Wingrove Oct 30 (Reuters) - AstraZeneca on Friday unveiled plans to save some $1.5 billion annually to invest in its drug pipeline, sparking the biggest one-day share rally in a year as CEO Pascal Soriot moved to shift the focus back to growth after a turbulent few months.
By Pushkala Aripaka and Patrick Wingrove Oct 30 (Reuters) - AstraZeneca on Friday unveiled plans to save some $1.5 billion annually to invest in its drug pipeline, sparking the biggest one-day share rally in a year as CEO Pascal Soriot moved to shift the focus back to growth after a turbulent few months.
What's Your Reaction?
